Geneos Wealth Management Inc. Buys 7,084 Shares of Zoetis Inc. $ZTS

Geneos Wealth Management Inc. boosted its stake in Zoetis Inc. (NYSE:ZTS) by 48.2% during the 1st quarter, HoldingsChannel reports. The fund owned 21,789 shares of the company’s stock after acquiring an additional 7,084 shares during the quarter. Geneos Wealth Management Inc.’s holdings in Zoetis were worth $3,588,000 as of its most recent SEC filing.

Several other institutional investors have also added to or reduced their stakes in ZTS. Nuveen LLC bought a new stake in Zoetis in the 1st quarter valued at $616,375,000. Sarasin & Partners LLP bought a new stake in Zoetis in the 1st quarter valued at $339,111,000. Mackenzie Financial Corp lifted its position in Zoetis by 4,158.3% in the 1st quarter. Mackenzie Financial Corp now owns 1,824,967 shares of the company’s stock valued at $300,481,000 after acquiring an additional 1,782,110 shares in the last quarter. GAMMA Investing LLC lifted its position in Zoetis by 14,731.3% in the 1st quarter. GAMMA Investing LLC now owns 1,759,285 shares of the company’s stock valued at $289,666,000 after acquiring an additional 1,747,423 shares in the last quarter. Finally, Polen Capital Management LLC lifted its position in Zoetis by 17.6% in the 1st quarter. Polen Capital Management LLC now owns 8,796,847 shares of the company’s stock valued at $1,448,401,000 after acquiring an additional 1,313,653 shares in the last quarter. 92.80% of the stock is owned by institutional investors.

Analysts Set New Price Targets

ZTS has been the topic of several research reports. Leerink Partners cut shares of Zoetis from an “outperform” rating to a “market perform” rating and cut their price objective for the company from $180.00 to $155.00 in a research report on Thursday, July 17th. Leerink Partnrs cut shares of Zoetis from a “strong-buy” rating to a “hold” rating in a research report on Thursday, July 17th. Piper Sandler boosted their price target on shares of Zoetis from $210.00 to $215.00 and gave the stock an “overweight” rating in a research report on Monday, August 11th. Argus reissued a “buy” rating and set a $190.00 price target on shares of Zoetis in a research report on Tuesday. Finally, Stifel Nicolaus cut shares of Zoetis from a “buy” rating to a “hold” rating and cut their price target for the stock from $165.00 to $160.00 in a research report on Wednesday, June 18th. Five equities research analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the company’s stock. According to MarketBeat.com, Zoetis has a consensus rating of “Moderate Buy” and a consensus target price of $200.88.

Zoetis Trading Down 0.2%

Shares of NYSE:ZTS opened at $149.45 on Thursday. The stock has a market capitalization of $66.24 billion, a PE ratio of 25.72, a price-to-earnings-growth ratio of 2.40 and a beta of 0.89. The company’s 50-day moving average price is $152.70 and its two-hundred day moving average price is $157.56. Zoetis Inc. has a one year low of $139.70 and a one year high of $200.33. The company has a debt-to-equity ratio of 1.05, a current ratio of 1.76 and a quick ratio of 1.04.

Zoetis (NYSE:ZTS) last released its quarterly earnings data on Tuesday, August 5th. The company reported $1.76 earnings per share for the quarter, topping the consensus estimate of $1.62 by $0.14. The company had revenue of $2.46 billion for the quarter, compared to analyst estimates of $2.41 billion. Zoetis had a net margin of 27.83% and a return on equity of 56.90%. Zoetis’s revenue for the quarter was up 4.2% compared to the same quarter last year. During the same period in the previous year, the business earned $1.56 EPS. Zoetis has set its FY 2025 guidance at 6.300-6.400 EPS. On average, equities analysts forecast that Zoetis Inc. will post 6.07 EPS for the current fiscal year.

About Zoetis

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.